imiquimod has been researched along with Skin Aging in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| DeWane, ME; Grant-Kels, JM; Kelsey, A; Oliviero, M; Rabinovitz, H | 1 |
| Altalhab, S | 1 |
| Goldenberg, G; Kaur, M; Smith, CC; Swanson, N | 1 |
| Kerl, H; Kopera, D | 1 |
| Barland, CO; Brown, BS; Elias, PM; Ghadially, R; Ye, J; Zettersten, E | 1 |
| Cornelison, R; Crowson, AN; Haque, R; Metcalf, S; Naylor, M | 1 |
| Germain, M; Hamza, S; Skelton, H; Smith, K | 1 |
1 review(s) available for imiquimod and Skin Aging
| Article | Year |
|---|---|
Melanoma on chronically sun-damaged skin: Lentigo maligna and desmoplastic melanoma.
Topics: B7-H1 Antigen; Biopsy; Dermatologic Surgical Procedures; Dermoscopy; Diagnosis, Differential; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Immunotherapy; Margins of Excision; Microscopy, Confocal; Mutation Rate; Neoplasm Invasiveness; Neurofibromin 1; Proto-Oncogene Proteins c-kit; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Skin; Skin Aging; Skin Neoplasms; Sunlight; Treatment Outcome | 2019 |
3 trial(s) available for imiquimod and Skin Aging
| Article | Year |
|---|---|
Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: two phase 3, multicenter, randomized, double-blind, placebo-controlled studies.
Topics: Adjuvants, Immunologic; Adult; Aminoquinolines; Dose-Response Relationship, Drug; Double-Blind Method; Face; Female; Humans; Imiquimod; Keratosis, Actinic; Male; Middle Aged; Scalp; Skin Aging; Treatment Outcome | 2014 |
Imiquimod as an antiaging agent.
Topics: Aminoquinolines; Antineoplastic Agents; Cell Count; Collagen; Dermis; Drug Administration Schedule; Epidermis; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Melanins; Melanocytes; Ointments; Skin Aging; Skin Neoplasms | 2007 |
Does imiquimod histologically rejuvenate ultraviolet radiation-damaged skin?
Topics: Aminoquinolines; Biopsy; Dermatologic Agents; Female; Humans; Imiquimod; Immunohistochemistry; Keratosis; Male; Middle Aged; Photosensitivity Disorders; Pilot Projects; Rejuvenation; Signal Transduction; Skin; Skin Aging; Skin Diseases; Sunlight; Ultraviolet Rays | 2007 |
3 other study(ies) available for imiquimod and Skin Aging
| Article | Year |
|---|---|
The effectiveness of imiquimod 5% cream as an anti-wrinkle treatment: A pilot study.
Topics: Adult; Face; Female; Healthy Volunteers; Humans; Imiquimod; Male; Middle Aged; Off-Label Use; Photography; Pilot Projects; Prospective Studies; Skin; Skin Aging; Skin Cream; Treatment Outcome | 2019 |
Detection and treatment of preclinical actinic keratoses (PAK).
Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Squamous Cell; Facial Dermatoses; Female; Humans; Imiquimod; Keratosis, Actinic; Middle Aged; Neoplasms, Radiation-Induced; Precancerous Conditions; Skin Aging | 2010 |
Imiquimod-induced interleukin-1 alpha stimulation improves barrier homeostasis in aged murine epidermis.
Topics: Adjuvants, Immunologic; Aging; Aminoquinolines; Animals; Cells, Cultured; Epidermis; Homeostasis; Humans; Imiquimod; Interleukin 1 Receptor Antagonist Protein; Interleukin-1; Keratinocytes; Lipid Metabolism; Mice; Mice, Inbred Strains; Microscopy, Electron; Permeability; Sialoglycoproteins; Skin Aging | 2004 |